Subscribe
81
Yan Chun
Oncology
About me
Graduated from the Clinical Medicine Department of Qingdao Medical College, has been working in the Oncology Department since 2001, obtained the qualification of attending physician in the same year. Promoted to attending physician in 2003. Qualified as associate chief physician in 2011. Participated in advanced studies at Jinan Cancer Hospital from June to November 2015. Serves as a youth member of the Chemical Therapy Committee in Shandong Province, youth member of the Elderly Therapy Committee of the Qingdao Anti-cancer Association, and a member of the Biologic Therapy Committee of the Qingdao Anti-cancer Association.
Proficient in diseases
Chemotherapy, radiotherapy, deep hyperthermia, targeted therapy, and endocrine therapy for various tumors such as stomach cancer, colorectal cancer, lung cancer, breast cancer, ovarian cancer, and pancreatic cancer.
Voices
Does early-stage liver cancer metastasize?
Patients with early-stage liver cancer generally do not experience metastasis. This is because for patients with early-stage liver cancer, the lesions are localized and have not spread, thus being classified as early-stage. Moreover, the general treatment for patients with early-stage liver cancer involves curative surgery. Since the lesions are localized, in most cases, there will be no recurrence or metastasis after the surgery. Therefore, for early-stage patients, there is no need to administer adjuvant radiotherapy or adjuvant chemotherapy and other anti-tumor treatments after the surgery. However, once the liver cancer lesions invade surrounding tissues and metastasize to distant sites, it indicates that the lesions have spread, and the clinical stage has progressed to mid or late stages, losing the opportunity for curative surgery. Most patients undergo comprehensive treatments such as radiotherapy, chemotherapy, and targeted therapy which generally results in a reduction in survival time.
Will prostate cancer embryonic antigen rise?
Prostate cancer is a common malignant tumor in the male urinary system. In some patients with prostate issues, there may be an increase in the carcinoembryonic antigen index in blood tests, but not all patients will exhibit this marker increase. Most prostate cancer patients will show an increase in the prostate-specific antigen (PSA) in blood tests, or there may be abnormal ratios of free PSA to bound PSA. Carcinoembryonic antigen and prostate-specific antigen are tumor markers for prostate cancer, but they only provide auxiliary value for diagnosis and do have some evaluative value regarding the effectiveness of anti-tumor treatment. Additionally, they can serve as a monitor for the condition of prostate cancer. Clinically, to confirm a diagnosis of prostate cancer, it is necessary to rely on the results of pathological tissue obtained through biopsy.
Early symptoms and manifestations of pancreatic cancer
Pancreatic cancer is a type of malignant tumor that has seen an increase in incidence in recent years. The early symptoms and signs of pancreatic cancer include the following: many patients experience abdominal pain, which often radiates to the shoulder and back. Additionally, some patients with early-stage pancreatic cancer may develop jaundice in the skin and mucous membranes, and some may even exhibit bleeding spots. Moreover, some patients with early-stage pancreatic cancer may show symptoms of indigestion, experiencing repeated belching, nausea, and loss of appetite. Furthermore, the symptoms of early-stage pancreatic cancer are generally not typical because the tumor is located deep within the body and is small, hence it does not invade surrounding tissues. Therefore, the clinical symptoms are neither severe nor diverse.
How to determine if a hemangioma is regressing
Clinically, hemangiomas are a type of benign tumor that mostly require medication, surgery, or local treatments to regress. In rare cases, hemangiomas can regress spontaneously, especially when they are small and the underlying cause of the hemangioma has been removed. Then, the color of the hemangioma may change from its original dark red to a bright red, and gradually change to a color similar to that of normal skin, indicating that the hemangioma has regressed. Clinically, depending on the impact of the hemangioma on the patient, treatment options can include medication, local microwave therapy, laser treatments, or surgical removal.
What are the symptoms of pancreatic cancer?
Pancreatic cancer is a malignant tumor of the digestive system and its incidence has been increasing year by year. The symptoms of pancreatic cancer patients mainly include the following clinically: 1. Abdominal pain, which is a common manifestation in pancreatic cancer patients. It appears as intermittent pain in the early stages and as persistent severe abdominal pain in the middle and late stages. 2. Jaundice, especially common in patients with cancer of the head of the pancreas, tends to appear early. This jaundice is due to the compression of the bile duct by the tumor, often presenting as obstructive jaundice. Patients may also experience dark tea-colored urine and pale clay-colored stools. Additionally, pancreatic cancer patients may also experience symptoms like weight loss, fatigue, fever, and when the cancer metastasizes to other organs, symptoms related to the metastases may appear.
What are the symptoms and early signs of ovarian cancer?
The symptoms and early signs of ovarian cancer mainly include the following aspects. Patients may experience persistent lower abdominal pain for no apparent reason, and some patients may experience radiating pain in the vulvar area, while others may show early clinical signs of abdominal bloating. The symptoms and early signs of ovarian cancer are not very numerous. Some patients may exhibit menstrual irregularities, such as increased or decreased menstruation, prolonged periods, or irregular vaginal bleeding. A few patients may experience abnormal vaginal discharge, which can be mixed with an unusual odor and a small amount of blood.
Early-stage liver cancer: how to exercise daily
Patients with early-stage liver cancer can engage in light and low-intensity exercises daily, such as slow walking and strolling. This is because early-stage liver cancer patients generally have an acceptable physical condition, although most of them have low immunity. Doing some appropriate exercises can enhance the patients’ immune system and has minimal impact on their overall physical condition. Moreover, patients with early-stage liver cancer usually undergo curative surgery for treatment. In most cases, post-surgery, they do not require radiation, chemotherapy, or targeted therapy for tumor treatment. With close follow-up, as long as there is no recurrence or metastasis, most patients can achieve clinical cure. Early exercise is beneficial for the recovery of patients, thus it is recommended. In addition, for patients with early-stage liver cancer, close follow-up of the disease changes after curative surgery is crucial to provide timely treatment.
Can early-stage liver cancer be cured by resection?
Liver cancer is one of the common malignant tumors of the digestive system. For patients with early-stage liver cancer, clinical cure is possible after curative surgery. This clinical cure refers to instances where liver cancer patients, after undergoing curative surgery, do not show signs of recurrence or metastasis over a period exceeding five years. This means there is no invasion of surrounding tissues and no metastasis to distant organs – effectively, the patients have achieved clinical cure. Patients' survival time exceeds five years, or even longer. Therefore, for patients with early-stage liver cancer, because their lesions are relatively limited, achieving clinical cure is possible following curative surgery. However, as the disease progresses to the mid and late stages, even with aggressive surgery and postoperative adjuvant radiotherapy or chemotherapy, most patients cannot achieve clinical cure.
Is prostate cancer stage T2 considered early or mid-stage?
Prostate cancer stage T2 is considered early or intermediate, but it is also necessary to understand the patient's N and M status. If the patient is at stage T2, and both N and M are at stage 0, then it is considered early-stage prostate cancer. If the primary lesion is at stage T2, but N1 is present and there is no metastasis (M), then the patient is considered to have intermediate-stage prostate cancer. If the primary lesion is at stage T2, but there is metastasis in N and M, then the patient's clinical stage is considered advanced. The clinical staging of prostate cancer not only requires understanding of the primary lesion T, but also involves the regional lymph nodes N and distant metastasis M.
What causes pancreatic cancer?
Pancreatic cancer is a malignant tumor of the digestive system whose incidence has gradually increased in recent years. The exact cause of pancreatic cancer is still unclear, but there are several factors that can increase the incidence of pancreatic cancer: 1. Age factor: Statistical data shows that the incidence of pancreatic cancer increases with age. 2. Dietary factors: Clinical research data confirms that some poor eating habits, such as consuming too much high-fat and animal protein, can significantly increase the incidence of pancreatic cancer. 3. Unhealthy lifestyle habits: People who smoke heavily and drink alcohol over a long period have a significantly higher incidence of pancreatic cancer compared to the general population. 4. Other benign pancreatic diseases, such as diabetes: Statistical data indicates that among diabetic patients, especially those with Type 2 diabetes, there is a slight increase in the incidence of pancreatic cancer.